Dr Derek S. Gilchrist PhD, Co-founder CEO and CSO
Derek is a bio-medical research scientist with 20 years of molecular biology experience. He graduated with a degree in Molecular Biology from University of Glasgow before completing his PhD at the University of Liverpool. Working at the University of Edinburgh he developed transgenic technologies to study the embryonic origin of the haematopoietic system. Returning to Glasgow he investigated the role of microRNAs in the pathogenesis of rheumatoid arthritis. During this time, he discovered the differential targeting of collagen type 1 and 3 by miR-29a. Derek leads the scientific and commercial TenoMiR. Derek graduated from INSEAD’s Entrepreneurs in Clinical Academia Course and MIT’s Entrepreneurship Development Program. Derek has an honorary Senior Lecturer position at the University of Glasgow.
Derek is a bio-medical research scientist with 20 years of molecular biology experience. He graduated with a degree in Molecular Biology from University of Glasgow before completing his PhD at the University of Liverpool. Working at the University of Edinburgh he developed transgenic technologies to study the embryonic origin of the haematopoietic system. Returning to Glasgow he investigated the role of microRNAs in the pathogenesis of rheumatoid arthritis. During this time, he discovered the differential targeting of collagen type 1 and 3 by miR-29a. Derek leads the scientific and commercial TenoMiR. Derek graduated from INSEAD’s Entrepreneurs in Clinical Academia Course and MIT’s Entrepreneurship Development Program. Derek has an honorary Senior Lecturer position at the University of Glasgow.
